ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,040.53
-0.50%
US Tech 100
20,818.00
-0.50%
다우존스 지수
44,544.66
-0.75%
Bitcoin
102,286.94
-0.12%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Clearside Biomedical Inc (CLSD) 시세

Clearside Biomedical Inc

Clearside Biomedical Inc (CLSD)

NASDAQ
0.93
-0.015
(-1.59%)
마감 01 2월 6:00AM
15분 지연
0.9499
0.0199
(2.14%)
시간외 거래: 9:40AM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
0.9499
매수가
0.91
매도가
0.945
거래량
68,324
0.92 일간 변동폭 0.95
0.801 52주 범위 2.12
market_cap
72.044M
전일 종가
0.945
개장가
0.9401
최근 거래 시간
100
@
0.9499
(formt)
마지막 거래 시간
재정 규모
US$ 64,228
VWAP
0.940046
평균 볼륨(3m)
248,083
발행 주식
75,843,504
배당수익률
-
주가수익률
-2.17
주당순이익(EPS)
-0.43
매출
8.23M
순이익
-32.49M

Clearside Biomedical Inc 정보

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual functio... Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.clearsidebio.com
본부
Wilmington, Delaware, USA
설립됨
-
Clearside Biomedical Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker CLSD. The last closing price for Clearside Biomedical was US$0.95. Over the last year, Clearside Biomedical shares have traded in a share price range of US$ 0.801 to US$ 2.12.

Clearside Biomedical currently has 75,843,504 shares in issue. The market capitalisation of Clearside Biomedical is US$71.67 million. Clearside Biomedical has a price to earnings ratio (PE ratio) of -2.17.

CLSD 최신 뉴스

추가 뉴스

Clearside Biomedical Announces Multiple Medical Meeting Presentations Focused on the Advantages of Suprachoroidal Delivery and Key Differentiators in its CLS-AX Clinical Program

- Upcoming Presentations at Angiogenesis and Macula Society Conferences to Feature CLS-AX Sub-Group Analyses from ODYSSEY Wet AMD Trial - - CLS-AX Targets Flexible Dosing of Biologics with...

28 1월 2025
GlobeNewswire Inc.

Clearside Biomedical Announces its Asia-Pacific Partner, Arctic Vision, Received Approval of Suprachoroidal Treatment for Uveitic Macular Edema in Australia and Singapore

- ARCATUS®, Branded as XIPERE® in the U.S., is the First Globally Approved Suprachoroidal Therapy - - Continued Global Expansion of Clearside’s Suprachoroidal Space Injection Platform Featuring...

22 1월 2025
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

11 1월 2025
Edgar (US Regulatory)

Clearside Biomedical Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, Eye

ALPHARETTA, Ga., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through...

19 12월 2024
GlobeNewswire Inc.

Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States

- Commercial, Clinical and Regulatory Expertise Establish Clearside as the Leader in Suprachoroidal Delivery - - Multiple Events at Asia-Pacific Vitreo-Retina Society Congress Highlighting...

25 11월 2024
GlobeNewswire Inc.

Form 8-K - Current report

13 11월 2024
Edgar (US Regulatory)

Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update

- Recent ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieved All Primary and Secondary Outcomes - - Positive Topline Results Support Advancing CLS-AX to Phase 3 Targeting a...

13 11월 2024
GlobeNewswire Inc.

Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema

- Partnership Creates New Opportunities to Address Unmet Needs Related to Posterior Segment Eye Diseases in China - - Agreement Provides Additional Validation for Clearside’s Suprachoroidal Space...

07 11월 2024
GlobeNewswire Inc.

Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference

ALPHARETTA, Ga., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through...

06 11월 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

05 11월 2024
Edgar (US Regulatory)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.03483.802863075070.91510.960.91258140.92759422CS
4-0.0051-0.5340314136130.9551.01760.91350410.94672693CS
12-0.2101-18.11206896551.161.160.8012480830.98965602CS
26-0.1901-16.67543859651.141.650.8014878411.18245924CS
52-0.4001-29.6370370371.352.120.8013810051.2787172CS
156-0.9201-49.20320855611.872.850.6501013136321.46565149CS
260-2.6001-73.24225352113.557.730.6501015105502.979775CS

CLSD - Frequently Asked Questions (FAQ)

What is the current Clearside Biomedical share price?
The current share price of Clearside Biomedical is US$ 0.9499
How many Clearside Biomedical shares are in issue?
Clearside Biomedical has 75,843,504 shares in issue
What is the market cap of Clearside Biomedical?
The market capitalisation of Clearside Biomedical is USD 71.67M
What is the 1 year trading range for Clearside Biomedical share price?
Clearside Biomedical has traded in the range of US$ 0.801 to US$ 2.12 during the past year
What is the PE ratio of Clearside Biomedical?
The price to earnings ratio of Clearside Biomedical is -2.17
What is the cash to sales ratio of Clearside Biomedical?
The cash to sales ratio of Clearside Biomedical is 8.57
What is the reporting currency for Clearside Biomedical?
Clearside Biomedical reports financial results in USD
What is the latest annual turnover for Clearside Biomedical?
The latest annual turnover of Clearside Biomedical is USD 8.23M
What is the latest annual profit for Clearside Biomedical?
The latest annual profit of Clearside Biomedical is USD -32.49M
What is the registered address of Clearside Biomedical?
The registered address for Clearside Biomedical is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Clearside Biomedical website address?
The website address for Clearside Biomedical is www.clearsidebio.com
Which industry sector does Clearside Biomedical operate in?
Clearside Biomedical operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
729.71M
REBNReborn Coffee Inc
US$ 3.31
(63.05%)
55.54M
FCUVFocus Universal Inc
US$ 5.87
(56.62%)
1.73M
SOPASociety Pass Inc
US$ 1.54
(56.50%)
13.82M
CYCNCyclerion Therapeutics Inc
US$ 3.92
(54.33%)
82.39M
ENVBEnveric Biosciences Inc
US$ 2.0899
(-46.41%)
1.57M
NIVFNewGenIvf Group Ltd
US$ 0.1489
(-42.51%)
14.8M
GLSTGlobal Star Acquisition Inc
US$ 8.83
(-39.10%)
23.89k
PRPHProPhase Labs Inc
US$ 0.2633
(-38.02%)
872.26k
SPGCSacks Parente Golf Inc
US$ 0.5601
(-37.86%)
7.27M
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
729.71M
NVDANVIDIA Corporation
US$ 120.07
(-3.67%)
388.53M
RIMEAlgorhythm Holdings Inc
US$ 0.02565
(5.12%)
338.7M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0355
(-11.25%)
236.05M
CLEUChina Liberal Education Holdings Ltd
US$ 0.1938
(30.77%)
234.74M

CLSD Discussion

게시물 보기
georgie18 georgie18 1 월 전
CLSD...95...🥳...Setting up for $1.20 Break...imo...we shall see... https://schrts.co/nhFdXepw

CLSD...$1.45...🥳...ALPHARETTA, Ga., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that the ODYSSEY Phase 2b clinical trial of CLS-AX (axitinib injectable suspension) for the treatment of neovascular age-related macular degeneration (wet AMD) achieved both its primary and secondary outcomes. In participants who received CLS-AX delivered suprachoroidally, best corrected visual acuity (BCVA) and ocular anatomy (central subfield thickness) were stable up to 6 months compared to participants who received aflibercept. In addition, CLS-AX demonstrated a well-tolerated safety profile to Week 36 inclusive of mandatory re-dosing of CLS-AX at Week 24.
👍️0
Invest-in-America Invest-in-America 4 월 전
CLSD: Nice news for sure, but heavy FLOAT of 63-million..
👍️0
Awl416 Awl416 4 월 전
Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes
👍️0
BBANBOB BBANBOB 4 월 전
CLSD 1.52
👍️0
BBANBOB BBANBOB 5 월 전
CLSD under 1$ @ .9355
👍️0
Monksdream Monksdream 5 월 전
CLSD under $2
👍️0
Monksdream Monksdream 7 월 전
CLSD under $2
👍️0
Monksdream Monksdream 9 월 전
CLSD under $2
👍️0
BBANBOB BBANBOB 10 월 전
I'll suggest now that the GAP FILLED yesterday and it takes news 2-3 days to be digested, tomorrow we hopefully head back to the 2$ area, just my WAG bwthdik
👍️0
BBANBOB BBANBOB 11 월 전
WHO KNOWS PARD WHO KNOWS
👍️ 1
BBANBOB BBANBOB 11 월 전
.
👍️0
jhdf51 jhdf51 11 월 전
Great..well maybe just maybe we are finally on our way albeit perhaps a bumpy ride...

JHD
👍️0
BBANBOB BBANBOB 11 월 전
JHD

NOT really GAP filled and has held up very well, next surge is on its way and still say this will close on FRI over $2

Vol is holding UPPPPPPPP well so, something is up here, from 2.12 to 1.47 was a major head fake to close the gap imho and probably casue a lot to part with some shares WHIH imho is exactly what they wanted...............
👍️0
jhdf51 jhdf51 11 월 전
Same ol same ol
👍️0
BBANBOB BBANBOB 11 월 전
WE BOTH HAVE THE SAME PROBLEM

DNDN been there done that and not again
👍️ 1
BBANBOB BBANBOB 11 월 전
.53 cent loss versus .55 loss last yr
👍️0
jhdf51 jhdf51 11 월 전
Yep..I was thinking of getting out but same...
👍️0
BBANBOB BBANBOB 11 월 전
Not REAL THRILLED with the earnings to be released AH's that is normally indicative of bad numbers, so looks like the 2.12 was a head fake for some to get out
I came close to selling 50% yesterday and get back in when it closes the gap @ 1.54,,,,,,, but just couldn't find the CAJONES to do it..........OH WELL NO BALLS NO BLACK CHIPS
👍️0
BBANBOB BBANBOB 11 월 전
Appears they are playing this real hard to get shares all the way to 1.81 from 2.12
👍️0
BBANBOB BBANBOB 11 월 전
1.87 NEW annual high and HOD. 3 trade days ago we did 3 mill shares and VOL proceeds PPS

MY WAG is this is over 2$ by weeks end.

AND NO not pumping this since I have held it for over 2 yrs NOV of 2022 and @ $4.86 finally got my avg to $2.00
👍️0
Monksdream Monksdream 11 월 전
CLSD 10Q due March 12
👍️0
Monksdream Monksdream 11 월 전
CLSD new 52 week hi
👍️0
glenn1919 glenn1919 11 월 전
CLSD....................................................https://stockcharts.com/h-sc/ui?s=CLSD&p=W&b=5&g=0&id=p86431144783
👍️0
BBANBOB BBANBOB 11 월 전
And on VERY GOOD VOL, me thinks something is up
👍️0
Monksdream Monksdream 11 월 전
CLSD new 52 week high
👍️0
Monksdream Monksdream 11 월 전
CLSD under $2
👍️0
BBANBOB BBANBOB 1 년 전
OOOOOOOOOOOOOPS $1.47
👍️0
BBANBOB BBANBOB 1 년 전
OPPPPPPPPPPPPPPS .6951
👍️0
BBANBOB BBANBOB 1 년 전
APPEARS we just made a new one too DAMN @ .70

I'm hoping they are tanking it in front of good earning to pick it up I KNOWWWWWWWWWWWWWWWWWWWWWWWWWWWW
👍️0
Monksdream Monksdream 1 년 전
CLSD new 52 week low
👍️0
Monksdream Monksdream 1 년 전
CLSD new 52 week low
👍️0
Monksdream Monksdream 1 년 전
CLSD new 52 week low
👍️0
Monksdream Monksdream 1 년 전
CLSD new 52 week low
👍️0
heyitsmeagain heyitsmeagain 2 년 전
Here we go
👍️0
heyitsmeagain heyitsmeagain 2 년 전
Loaded for this runner. Wish I had more loot.
👍️0
BBANBOB BBANBOB 3 년 전
Hard to Borrow is back on CLSD today
👍️0
BBANBOB BBANBOB 3 년 전
FYI

THE HARD TO BORROW classification(at Schwab) just went POOF GHONDI as of today on CLSD and at the same time its is up 3.81%

HMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMM
👍️0
BBANBOB BBANBOB 3 년 전
Well so far so good !!!!!!!!!!!!!!!!!! Let's say for grins $3 on Fri
👍️0
BBANBOB BBANBOB 3 년 전
Well well let's give this news 2-3 days to digest and see where it is by weeks end.

Also if if if this is gonna take off as I believe, the first part of the week MIGHT JUST SCARE THE WEAK here.

If you're faint at heart or can't handle pressure, one might want to JUST NOT LOOK for the next few days
👍️0
jhdf51 jhdf51 3 년 전
Now that would be perfect. I’d hire me a farm hand, or two, or three! Lol

JHD
👍️0
BBANBOB BBANBOB 3 년 전
Again

Earnings was a beat and they were .31 for the LAST quarter PER SHARE, do that X's a whole yr and then X's a multiple of 10-12 and there ya have it.

NOW Since this appears to be JUST the start of licensing, who knows how many more licenses will be entered into in the next year.

MY PPS prediction would be along the lines of $27-$35 in the next 12 months WAG and IMHO
👍️0
jhdf51 jhdf51 3 년 전
Yes I agree. Definitely could be. Dang Price targets are never exact anyway.
👍️0
BBANBOB BBANBOB 3 년 전
I'll take $9 for this year, but still say it will be more.
👍️0
jhdf51 jhdf51 3 년 전
I see $9. $18 was last year.

https://www.google.com/amp/s/www.marketbeat.com/instant-alerts/nasdaq-clsd-a-buy-or-sell-right-now-2022-03-2/amp/
👍️0
BBANBOB BBANBOB 3 년 전
But all companies good or bad always have HEDGE FUNDS that short their stock, THUS the meaning of HEDGE, being on both sides of the trade, much like a BOOKIE taking sports bets will take EITHER SIDE of a bet.

BUT unlike a bookie that takes your bet and at half time IS WAY UPSIDE down on the bet he made with you, HE DOES NOT HAVE THE OPPORTUNITY to CHANGE his bet, SHORTS DO at any given time

THUNK ABOUT IT BOYZZZZZZZZZZZ
👍️0
BBANBOB BBANBOB 3 년 전
SHORTS

Again as I did last week, I would serious suggest that you close even the few shorts you have still open here, as it might get REAL NASTY if ya don't, JUST SAYING
👍️0
BBANBOB BBANBOB 3 년 전
Having NOT been able to take part in PICKING UP SHARES last week, I just got back to even as of today at one point. IF IF IF it closes over 2.39 today, then FINALLY again I am BACK in the black.
👍️0
BBANBOB BBANBOB 3 년 전
Well YET AGAIN it seems my 3 day rule on it taking 3 days for news to be fully digested before a stock rises,has yet again proven itself true..
👍️0
BBANBOB BBANBOB 3 년 전
CRUDEOIL

I have always suggested on these boards that, ""IT TAKE 3 days for news to be really digested before ya see real up swings, HMMMMMMMM
👍️0
BBANBOB BBANBOB 3 년 전
OH I agree 100% and suggested that ALL for the last months JUST SIT ON THEIR HANDS or add.....

Me aint got no dry powder or I would have last week and large
👍️0

최근 히스토리

NASDAQ
CLSD
Clearside Biomedical
LATK
MARSHUSDT
UnmarshalToken
BIT
IEAC
Exchange Traded
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지